News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thorp Clay
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Exercised 3,750 restricted stock units
@ $0 |
|
| 12/21/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 14,000 shares
@ $1.019, valued at
$14.3k
|
|
| 12/19/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Disposed of 1,406,507 shares
@ $0
Acquired 8,522 shares
@ $0 |
|
| 12/19/2022 |
4/A
| Thorp Clay (Director) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 32,873 shares
@ $4.43, valued at
$145.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 21,802 shares
@ $2.7622, valued at
$60.2k
Bought 14,893 shares
@ $2.9671, valued at
$44.2k
|
|
| 03/28/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 3,000 shares
@ $7.2014, valued at
$21.6k
|
|
| 01/11/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 1,254,335 shares
@ $0
Bought 265,000 shares
@ $14, valued at
$3.7M
Converted 2,552,021 preferred shares
@ $0
Converted 926,506 preferred shares
@ $0 |
|
| 01/06/2022 |
3
| Thorp Clay (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 3,000 shares
@ $3.67, valued at
$11k
Bought 2,000 shares
@ $3.5, valued at
$7k
|
|
| 11/18/2020 |
4
| Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Disposed of 52,397 shares
@ $0
Acquired 2,144 shares
@ $0
Acquired 10,586 shares
@ $0 |
|
| 06/19/2020 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 25,000 options to buy
@ $2, valued at
$50k
|
|
| 06/05/2020 |
4
| Thorp Clay (Director) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 16,000 options to buy
@ $4.86, valued at
$77.8k
|
|
| 11/26/2019 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 1,518,026 shares
@ $1.054, valued at
$1.6M
|
|
| 07/03/2019 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Sold 2,014 shares
@ $14, valued at
$28.2k
Sold 180 shares
@ $14, valued at
$2.5k
Sold 255 shares
@ $14, valued at
$3.6k
Sold 459 shares
@ $14, valued at
$6.4k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Sold 277 shares
@ $14, valued at
$3.9k
Sold 25 shares
@ $14, valued at
$350
Sold 35 shares
@ $14, valued at
$490
Sold 63 shares
@ $14, valued at
$882 |
|
| 05/13/2019 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Granted 11,000 options to buy
@ $13.23, valued at
$145.5k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Bought 8,000 shares
@ $1.36, valued at
$10.9k
|
|
| 12/06/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Bought 4,000 shares
@ $3.13, valued at
$12.5k
|
|
| 10/24/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Converted 52,690 shares
@ $0
Converted 1,683,420 shares
@ $0
Bought 137,513 shares
@ $5, valued at
$687.6k
Converted 150,612 shares
@ $0
Bought 12,487 shares
@ $5, valued at
$62.4k
Converted 4,846 shares
@ $0
Converted 266,481 shares
@ $0
Bought 150,000 shares
@ $5, valued at
$750k
Exercised 19,061 options to buy
@ $0.12, valued at
$2.3k
Exercised 19,061 preferred shares
@ $0.12, valued at
$2.3k
Sold 458 preferred shares
@ $5, valued at
$2.3k
|
|
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Granted 11,250 options to buy
@ $10.74, valued at
$120.8k
|
|
| 06/01/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 758,290 shares
@ $48, valued at
$36.4M
Sold 41,710 shares
@ $48, valued at
$2M
|
|
| 05/23/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 29,005 shares
@ $51.1604, valued at
$1.5M
Sold 1,595 shares
@ $51.0589, valued at
$81.4k
Sold 474 shares
@ $52.13, valued at
$24.7k
Sold 26 shares
@ $52.13, valued at
$1.4k
Sold 5,592 shares
@ $50.8593, valued at
$284.4k
Sold 308 shares
@ $50.6851, valued at
$15.6k
Sold 474 shares
@ $50.5, valued at
$23.9k
Sold 26 shares
@ $50.5, valued at
$1.3k
|
|
| 05/21/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 100,000 shares
@ $13.03, valued at
$1.3M
Sold 61,139 shares
@ $13.16, valued at
$804.6k
|
|
| 03/23/2018 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 100,000 shares
@ $12.27, valued at
$1.2M
Sold 33,630 shares
@ $12.07, valued at
$405.9k
Sold 5,231 shares
@ $12.02, valued at
$62.9k
|
|
| 12/07/2017 |
4
| Thorp Clay (10% Owner) has filed a Form 4 on Clearside Biomedical, Inc.|
Txns:
| Sold 15,000 shares
@ $6.37, valued at
$95.6k
Sold 15,000 shares
@ $6.09, valued at
$91.4k
Sold 5,000 shares
@ $6.13, valued at
$30.7k
|
|
|
|
|